SCHEMBL3787764

SCHEMBL3787764

O=Cc1ccc(Cl)c(C=O)c1

nearest known ligand 0.67

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.67
VCAM1 P19320 1/20 0.57
HSD17B10 Q99714 2/20 0.48
TDP1 Q9NUW8 2/20 0.46
ALDH1A3 P47895 3/20 0.46
KDM4E B2RXH2 3/20 0.43
PTGS2 P35354 1/20 0.43
RAB9A P51151 1/20 0.43
ALDH3A1 P30838 2/20 0.42
CYP2A6 P11509 1/20 0.41
TTR P02766 1/20 0.40
ERN1 O75460 3/20 0.39
TSHR P16473 1/20 0.39
ALDH5A1 P51649 1/20 0.38
ABAT P80404 1/20 0.38
TYR P14679 1/20 0.38
POLB P06746 1/20 0.38
MAPT P10636 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29818700 1.00 ALDH1A1 (0.67) ALDH1A1VCAM1HSD17B10TDP1ALDH1A3
SCHEMBL26908557 0.82 ALDH1A1 (0.47) ALDH1A1VCAM1HSD17B10TDP1ALDH1A3
SCHEMBL30493606 0.81 ALDH1A1 (0.67) ALDH1A1VCAM1HSD17B10TDP1ALDH1A3
SCHEMBL3122359 0.81 ALDH1A1 (0.67) ALDH1A1VCAM1HSD17B10TDP1ALDH1A3
SCHEMBL48577 0.80 ALDH1A1 (1.00) ALDH1A1VCAM1HSD17B10ALDH1A3KDM4E
SCHEMBL29364412 0.80 ALDH1A1 (1.00) ALDH1A1VCAM1HSD17B10ALDH1A3KDM4E
SCHEMBL26908606 0.80 ALDH1A1 (0.44) ALDH1A1VCAM1HSD17B10TDP1ALDH1A3
Water SCHEMBL28568603 0.79 ALDH1A1 (0.64) ALDH1A1VCAM1HSD17B10TDP1ALDH1A3
Hydrochloric Acid SCHEMBL28849470 0.78 ALDH1A1 (0.95) ALDH1A1VCAM1HSD17B10ALDH1A3KDM4E
SCHEMBL42560 0.78 TDP1 (0.67) ALDH1A1VCAM1HSD17B10TDP1ERN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-04-08 US disclosed
EP-1914221-A1 PROCESS FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-04-23 EP disclosed
CN-1146472-C Catalyst for catalyzing unsymmetrical hetero-Diels-Alder reaction, its preparation and application 中国科学院上海有机化学研究所 2004-04-21 CN disclosed
US-4172937-A REACTION OF A DIALDEHYDE AND DIAMINE IN A PHENOLIC COMPOUND ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) 1979-10-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND NISCH, BLVRB, BBOX1 ALDH1A1 4339/4885VCAM1 4526/4885HSD17B10 1100/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.